by John A. Jenkins | Apr 3, 2024 | FDA, FOIA, Law Firms, Medical Devices
FOIAengine: Neuralink’s High Profile Makes It a Target It was a Musk Moment unlike any other: Two weeks ago, the first human participant in Neuralink’s brain-implant trials took the stage to show how he could play chess by imagining where he wanted the pieces to go. ...
by John A. Jenkins | Mar 13, 2024 | FDA, FOIA, Law Firms, Non-Profits, Pharmaceuticals
FOIAengine Spotlights a Non-Profit Newsroom and Another Problem for the FDA The Food and Drug Administration was already under fire from Congress and others after hundreds of toddlers in 44 states were poisoned last year by lead-tainted pouches of apple puree and...
by John A. Jenkins | Mar 6, 2024 | FOIA, Litigation, Short-Selling, Stock Market
FOIAengine Previews an April Fool’s Day Courtrooom Grudge Match This week’s story is about two litigation magnets. One is a household name whose lawsuit against OpenAI dominated the news a few days ago. That would be Elon Musk. The other – Aaron Greenspan –...
by John A. Jenkins | Feb 7, 2024 | FOIA, FTC, Litigation
FOIAengine: Who’s Asking What, and Why? Days after the Federal Trade Commission launched an investigation of the five biggest players in artificial intelligence, Lina Khan was on a charm offensive aimed at winning the confidence of her biggest enemies on Wall...
by John A. Jenkins | Jan 31, 2024 | FDA, FOIA, SEC, Short-Selling, Stock Market
FOIAengine: Short Seller Fahmi Quadir Goes for Another Kill To keep a nickname like “the Assassin,” the killer better not miss. By the time short seller Fahmi Quadir was scheduled to take the stage on January 30 at a big investment conference in Miami Beach, she had...
